(Q39016331)

8 September 2017

title

Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer (English)

1 reference

8 September 2017

1 reference

Chunni Wang

1

1 reference

8 September 2017

Lin Wang

2

1 reference

8 September 2017

Bo Su

3

1 reference

8 September 2017

Ning Lu

4

1 reference

8 September 2017

Jingjing Song

5

1 reference

8 September 2017

Xiaoqing Yang

6

1 reference

8 September 2017

Weiwei Fu

7

1 reference

8 September 2017

Weiwei Tan

8

1 reference

8 September 2017

Bo Han

9

1 reference

8 September 2017

publication date

12 March 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

74

1 reference

8 September 2017

issue

7

1 reference

8 September 2017

page(s)

689-701

1 reference

Cancer genes and the pathways they control

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Molecular genetics of prostate cancer: new prospects for old challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Common gene rearrangements in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Recurrent gene fusions in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

The role of SPINK1 in ETS rearrangement-negative prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Therapeutic targeting of SPINK1-positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

The primary structure of the human pancreatic secretory trypsin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Targeting Wnt signaling: can we safely eradicate cancer stem cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Molecular biology of bcr-abl1-positive chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

CCN proteins: multifunctional signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Connective tissue growth factor is a positive regulator of epithelial-mesenchymal transition and promotes the adhesion with gastric cancer cells in human peritoneal mesothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

TMPRSS2-ERG gene fusion and clinicopathologic characteristics of Korean prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Detecting cancer outlier genes with potential rearrangement using gene expression data and biological networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22787

21 January 2018

Identifiers

DOI

10.1002/PROS.22787

1 reference

release_fwq7toalafc2fpc6qbcpawghxi

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fwq7toalafc2fpc6qbcpawghxi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference